alexa CAPA And Risk Management | 14183
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Summit on GMP, GCP & Quality Control

Rucha Majmundar Mehta
Accepted Abstracts: J Develop Drugs
DOI: 10.4172/2329-6631.S1.004
Abstract
The pharmaceutical company should have a system for implementing corrective actions and preventive actions resulting from the; investigation of complaints, Product rejections, Non- conformances, Recalls, deviations, Audits, Regulatory inspections and findings, and Trends from process performance and product quality monitoring. A structured approach to the investigation process should be used with the objective of determining the root cause. The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, In line with ICH Q9 ?Quality Risk Management?. CAPA methodology should result in product and process improvements and enhanced product and process understanding. Corrective Action: Corrective action is aiming to correct an existing non-conformity and to avoid reoccurrence of the same nonconformity. Corrective action may arise, from manufacturing deviations, OOS investigations, complaints, audit findings, recalls. A systematic investigation should be performed to determine the reason(s) for the non-conformities and to agree upon appropriate corrective action. All Agreed corrective actions should be closely followed-up and monitored till completion. Management should be notified about the costs and impact of failure including the respective corrective actions. Preventive Action: Preventive action should be aiming to avoid the initial occurrence of non-conformity by proactively implementing improvements. Preventive action may result from trending of in process data, of analytical data, of audit findings, Trending of root causes for non-conformities or complaints, From product quality reviews (annual product reviews), Quality risk analyses, etc. Similar to corrective actions, All Agreed Preventive Actions should be closely followed-up and monitored till their completion. Effectiveness of preventive actions should be reviewed regularly, as part of the product quality review (annual product review). Effective CAPA Process, CAPA Challenges & CAPA Management Software are the key factors
Biography
Rucha Majmundar Mehta is an independent GCP Auditor (Freelancer) since 6 years. She developed a Clinical Research Site in a privately owned small sized hospital and was heading the site till 2007. She provides QA consultation and training to various study sites and QA department of Pharmaceutical Companies, and conducts GCP Sessions during Investigators Meeting globally. She was practicing as a Clinical Nutritionist prior to changing her profession to Clinical Research. She has done post-graduate studies in Clinical Nutrition from G S Medical College Bombay - India. She received her training in clinical research from NIH - US, and has done GCP auditing course from BARQA-UK.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7